Suppr超能文献

KASP:一种快速鉴定恶性疟原虫耐药性的基因分型方法。

KASP: a genotyping method to rapid identification of resistance in Plasmodium falciparum.

机构信息

Malaria & Parasitic Emerging Diseases Laboratory, National Microbiology Center, Instituto de Salud Carlos III, Madrid, Spain.

Department of Clinical Microbiology, Hospital Universitario, 12 de Octubre, Madrid, Spain.

出版信息

Malar J. 2021 Jan 6;20(1):16. doi: 10.1186/s12936-020-03544-7.

Abstract

BACKGROUND

The emergence and spread of anti-malarial resistance continues to hinder malaria control. Plasmodium falciparum, the species that causes most human malaria cases and most deaths, has shown resistance to almost all known anti-malarials. This anti-malarial resistance arises from the development and subsequent expansion of Single Nucleotide Polymorphisms (SNPs) in specific parasite genes. A quick and cheap tool for the detection of drug resistance can be crucial and very useful for use in hospitals and in malaria control programmes. It has been demonstrated in different contexts that genotyping by Kompetitive Allele Specific PCR (KASP), is a simple, fast and economical method that allows a high-precision biallelic characterization of SNPs, hence its possible utility in the study of resistance in P. falciparum.

METHODS

Three SNPs involved in most cases of resistance to the most widespread anti-malarial treatments have been analysed by PCR plus sequencing and by KASP (C580Y of the Kelch13 gene, Y86N of the Pfmdr1 gene and M133I of the Pfcytb gene). A total of 113 P. falciparum positive samples and 24 negative samples, previously analysed by PCR and sequencing, were selected for this assay. Likewise, the samples were genotyped for the MSP-1 and MSP-2 genes, and the Multiplicity of Infection (MOI) and parasitaemia were measured to observe their possible influence on the KASP method.

RESULTS

The KASP results showed the same expected mutations and wild type genotypes as the reference method, with few exceptions that correlated with very low parasitaemia samples. In addition, two cases of heterozygotes that had not been detected by sequencing were found. No correlation was found between the MOI or parasitaemia and the KASP values of the sample. The reproducibility of the technique shows no oscillations between repetitions in any of the three SNPs analysed.

CONCLUSIONS

The KASP assays developed in this study were efficient and versatile for the determination of the Plasmodium genotypes related to resistance. The method is simple, fast, reproducible with low cost in personnel, material and equipment and scalable, being able to core KASP arrays, including numerous SNPs, to complete the main pattern of mutations associated to P. falciparum resistance.

摘要

背景

抗疟药物耐药性的出现和传播继续阻碍疟疾控制。引起大多数人类疟疾病例和大多数死亡的恶性疟原虫已对几乎所有已知的抗疟药物产生耐药性。这种抗疟药物耐药性源于特定寄生虫基因中单核苷酸多态性(SNP)的发展和随后的扩展。一种快速且廉价的耐药性检测工具对于医院和疟疾控制项目来说至关重要且非常有用。在不同的背景下已经证明,竞争性等位基因特异性 PCR(KASP)基因分型是一种简单、快速且经济的方法,可以高精度地对 SNP 进行双等位基因特征描述,因此它可能在恶性疟原虫耐药性研究中具有实用性。

方法

通过 PCR 加测序和 KASP 分析了与最广泛使用的抗疟药物耐药性相关的三种 SNP(Kelch13 基因的 C580Y、Pfmdr1 基因的 Y86N 和 Pfcytb 基因的 M133I)。共选择了 113 个疟原虫阳性样本和 24 个阴性样本进行此检测。同样,对 MSP-1 和 MSP-2 基因进行了基因分型,并测量了感染性倍数(MOI)和寄生虫血症,以观察它们对 KASP 方法的可能影响。

结果

KASP 结果显示与参考方法相同的预期突变和野生型基因型,但少数例外与极低寄生虫血症样本相关。此外,还发现了两个未通过测序检测到的杂合子病例。MOI 或寄生虫血症与样品的 KASP 值之间没有相关性。该技术的重现性表明,在分析的三个 SNP 中,任何一个重复之间都没有波动。

结论

本研究中开发的 KASP 检测方法对于确定与耐药性相关的恶性疟原虫基因型高效且多功能。该方法简单、快速、可重复,人员、材料和设备成本低,并且可扩展,能够进行 KASP 芯片核心,包括许多 SNP,以完成与恶性疟原虫耐药性相关的主要突变模式。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccc2/7789257/ffcd3471db55/12936_2020_3544_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验